Is 2 mm a wide margin in high-grade conventional chondrosarcomas of the pelvis?


Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
Jun 2021
Historique:
entrez: 1 6 2021
pubmed: 2 6 2021
medline: 5 6 2021
Statut: ppublish

Résumé

Controversy exists as to what should be considered a safe resection margin to minimize local recurrence in high-grade pelvic chondrosarcomas (CS). The aim of this study is to quantify what is a safe margin of resection for high-grade CS of the pelvis. We retrospectively identified 105 non-metastatic patients with high-grade pelvic CS of bone who underwent surgery (limb salvage/amputations) between 2000 and 2018. There were 82 (78%) male and 23 (22%) female patients with a mean age of 55 years (26 to 84). The majority of the patients underwent limb salvage surgery (n = 82; 78%) compared to 23 (22%) who had amputation. In total, 66 (64%) patients were grade 2 CS compared to 38 (36%) grade 3 CS. All patients were assessed for stage, pelvic anatomical classification, type of resection and reconstruction, margin status, local recurrence, distant recurrence, and overall survival. Surgical margins were stratified into millimetres: < 1 mm; > 1 mm but < 2 mm; and > 2 mm. The disease--specific survival (DSS) at five years was 69% (95% confidence interval (CI) 56% to 81%) and 51% (95% CI 31% to 70%) for grade 2 and 3 CS, respectively (p = 0.092). The local recurrence-free survival (LRFS) at five years was 59% (95% CI 45% to 72%) for grade 2 CS and 42% (95% CI 21% to 63%) for grade 3 CS (p = 0.318). A margin of more than 2 mm was a significant predictor of increased LRFS (p = 0.001). There was a tendency, but without statistical significance, for a > 2 mm margin to be a predictor of improved DSS. Local recurrence (LR) was a highly significant predictor of DSS, analyzed in a competing risk model (p = 0.001). Obtaining wide margins in the pelvis remains challenging for high-grade pelvic CS. On the basis of our study, we conclude that it is necessary to achieve at least a 2 mm margin for optimal oncological outcomes in patients with high-grade CS of the pelvis. Cite this article:

Identifiants

pubmed: 34058869
doi: 10.1302/0301-620X.103B6.BJJ-2020-1869.R1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1150-1154

Auteurs

Vineet Kurisunkal (V)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.

Minna K Laitinen (MK)

Dept of Orthopaedic and Traumatology, Helsinki University Central Hospital, Helsinki, Finland.

Yoichi Kaneuchi (Y)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.

Bilal Kapanci (B)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.

Jonathan Stevenson (J)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.

Michael C Parry (MC)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.

Aleksi Reito (A)

Department of Musculoskeletal Surgery and Diseases, Tampere University Hospital and University of Tampere, Faculty of Medicine and Life Sciences, Tampere, Finland.

Tomohiro Fujiwara (T)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.

Lee M Jeys (LM)

Oncology Department, The Royal Orthopaedic Hospital, Birmingham, UK.
Dept of Health and Life Sciences, Aston University, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH